春立医疗
(688236)
| 流通市值：13.30亿 | | | 总市值：64.32亿 |
| 流通股本：7929.47万 | | | 总股本：3.84亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,797,127,279.71 | 1,139,778,517.24 | 1,155,560,806.13 | 1,277,673,997.37 |
| 应收票据及应收账款 | 456,471,115.03 | 378,711,232.35 | 327,512,051.46 | 425,474,710.49 |
| 其中：应收票据 | 189,462,497 | 160,052,600 | 245,400 | 75,735,313.1 |
| 应收账款 | 267,008,618.03 | 218,658,632.35 | 327,266,651.46 | 349,739,397.39 |
| 预付款项 | 14,733,521.15 | 2,993,330.49 | 14,720,077.12 | 6,619,881.25 |
| 其他应收款合计 | 307,752.96 | 177,919.45 | 275,600.71 | 296,736.06 |
| 存货 | 561,223,487.42 | 550,842,677.89 | 577,945,443.16 | 520,397,879.92 |
| 其他流动资产 | 19,178,817.03 | 22,179,673.24 | 18,581,619.28 | 21,916,403.62 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,849,041,973.3 | 2,840,481,126 | 2,858,861,848.08 | 2,993,697,416.93 |
| 非流动资产: | | | | |
| 固定资产 | 306,852,546.27 | 311,008,174.74 | 307,611,045.16 | 311,861,259.48 |
| 在建工程 | 157,013,841.57 | 156,777,773.93 | 157,197,738.72 | 150,868,963.17 |
| 使用权资产 | 849,854.51 | 1,017,028.37 | 1,218,411.65 | 1,351,376.09 |
| 无形资产 | 126,594,895.15 | 127,569,991.24 | 130,345,087.33 | 133,120,183.42 |
| 商誉 | - | - | 13,359,553.09 | 13,359,553.09 |
| 递延所得税资产 | 26,803,568.01 | 26,113,029.08 | 25,126,253.07 | 25,643,613.31 |
| 其他非流动资产 | 6,375,725.58 | 2,767,859.62 | 1,098,177.61 | 3,003,786.5 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 624,490,431.09 | 625,253,856.98 | 635,956,266.63 | 639,208,735.06 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,473,532,404.39 | 3,465,734,982.98 | 3,494,818,114.71 | 3,632,906,151.99 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 198,903,468.21 | 227,845,174.6 | 211,476,114.16 | 224,093,248.17 |
| 应付账款 | 198,903,468.21 | 227,845,174.6 | 211,476,114.16 | 224,093,248.17 |
| 合同负债 | 116,318,303.36 | 128,563,190.58 | 227,592,166.08 | 166,451,250.34 |
| 应付职工薪酬 | 50,495,065.55 | 52,272,626.41 | 27,648,537.71 | 30,371,918.12 |
| 应交税费 | 9,138,600.75 | 6,656,073.81 | 4,318,707.84 | 18,323,718.11 |
| 其他应付款合计 | 64,852,803.63 | 69,459,231.16 | 71,867,425.33 | 195,764,287.77 |
| 应付股利 | - | - | - | 138,851,797 |
| 一年内到期的非流动负债 | 689,019.32 | 682,121 | 668,355.09 | 668,355.09 |
| 其他流动负债 | 56,801,268.33 | 61,266,897.36 | 57,176,812.73 | 84,538,713.08 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 497,198,529.15 | 546,745,314.92 | 600,748,118.94 | 720,211,490.68 |
| 非流动负债: | | | | |
| 租赁负债 | 149,736.77 | 184,315.07 | 257,660.53 | 251,946.43 |
| 递延收益 | 85,822,589.3 | 86,749,559.54 | 86,951,515.65 | 82,669,278.59 |
| 递延所得税负债 | 10,986,834.67 | 10,711,656.65 | 10,425,155.56 | 10,428,905.56 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 96,959,160.74 | 97,645,531.26 | 97,634,331.74 | 93,350,130.58 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 594,157,689.89 | 644,390,846.18 | 698,382,450.68 | 813,561,621.26 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 383,568,500 | 383,568,500 | 383,568,500 | 383,568,500 |
| 资本公积 | 1,044,799,419.83 | 1,044,799,419.83 | 1,044,799,419.83 | 1,044,799,419.83 |
| 减:库存股 | 12,018,864.19 | 12,018,864.19 | 5,038,831.4 | - |
| 盈余公积 | 201,343,486.94 | 195,115,661.94 | 181,585,925.26 | 181,585,925.26 |
| 未分配利润 | 1,260,280,858.59 | 1,208,437,565.7 | 1,189,894,867.81 | 1,207,687,290.07 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,877,973,401.17 | 2,819,902,283.28 | 2,794,809,881.5 | 2,817,641,135.16 |
| 少数股东权益 | 1,401,313.33 | 1,441,853.52 | 1,625,782.53 | 1,703,395.57 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,879,374,714.5 | 2,821,344,136.8 | 2,796,435,664.03 | 2,819,344,530.73 |
| 负债和股东权益合计 | 3,473,532,404.39 | 3,465,734,982.98 | 3,494,818,114.71 | 3,632,906,151.99 |
| 公告日期 | 2025-04-30 | 2025-03-29 | 2024-10-31 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |